4.7 Article

Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Dalbavancin as chronic antibiotic suppression therapy for left ventricular assist device driveline infection due to methicillin-resistant Staphylococcus aureus: a case report

Carlo Pallotto et al.

Summary: Left Ventricular Assist Devices (LVADs) are an important therapeutic option for advanced heart failure. This case report discusses the successful treatment of a 74-year-old male patient with a Jarvik 2000 (R) LVAD infection caused by methicillin-resistant Staphylococcus aureus (MRSA) using dalbavancin as a long-term antimicrobial therapy. The patient maintained a good quality of life for over 37 weeks without any adverse events. Dalbavancin could be a valid and safe treatment option for LVAD infections due to its efficacy and tolerability.

JOURNAL OF CHEMOTHERAPY (2023)

Article Infectious Diseases

Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source-a series of four cases

Florian Hitzenbichler et al.

Summary: Four cases of Gram-positive bacteremia originating from intravascular sources, including left ventricular assist devices, transfemoral aortic valve implantation, and prosthetic aortic valves, were effectively suppressed with dalbavancin therapy without significant side effects.

INFECTION (2021)

Letter Microbiology

Suppressive antibiotic treatment with dalbavancin. A case report

Jose Maria Barbero Allende et al.

REVISTA ESPANOLA DE QUIMIOTERAPIA (2021)

Article Pharmacology & Pharmacy

Dalbavancin is a novel antimicrobial against Gram-positive pathogens: clinical experience beyond labelled indications

Maria Nunez-Nunez et al.

EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2020)

Article Infectious Diseases

Subcutaneous suppressive antibiotic therapy for bone and joint infections: safety and outcome in a cohort of 10 patients

Cecile Pouderoux et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)

Review Infectious Diseases

Life-long antimicrobial therapy: where is the evidence?

Jillian S. Y. Lau et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)

Article Infectious Diseases

Suppressive therapy using azithromycin in 2 rare cases of recurrent staphylococcal infections

Vincent Grobost et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2014)

Article Infectious Diseases

Outcome of patients over 80 years of age on prolonged suppressive antibiotic therapy for at least 6 months for prosthetic joint infection

Virginie Prendki et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)

Review Infectious Diseases

Prosthetic joint infection: diagnosis and management

Javier Cobo et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)

Article Orthopedics

Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030

Steven Kurtz et al.

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2007)